Dieter Kabelitz Selected Research

Dieter Kabelitz Research Topics

Disease

59	Neoplasms (Cancer) 01/2022 - 01/2002
10	Infections 01/2022 - 01/2003
9	Adenocarcinoma 01/2020 - 12/2004
8	Inflammation (Inflammations) 01/2020 - 01/2003
7	Necrosis 02/2014 - 06/2002
6	Lymphoma (Lymphomas) 01/2021 - 06/2003
4	Leukemia 01/2019 - 12/2003
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 09/2007
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2011 - 12/2003
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2011
3	Multiple Myeloma 09/2017 - 06/2006
3	Hypersensitivity (Allergy) 11/2016 - 08/2010
3	Infertility (Sterility) 05/2016 - 09/2006
3	Neoplasm Metastasis (Metastasis) 03/2015 - 02/2008
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2006 - 06/2003
3	Hematologic Neoplasms (Hematological Malignancy) 06/2006 - 06/2003
2	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2017
2	Carcinoma (Carcinomatosis) 01/2019 - 10/2013
2	Melanoma (Melanoma, Malignant) 01/2019 - 12/2004
2	Glioma (Gliomas) 03/2018 - 04/2016
2	Carcinogenesis 01/2017 - 03/2015
2	Osteonecrosis (Kienbock's Disease) 07/2015 - 06/2014
2	Macular Degeneration (Age-Related Maculopathy) 02/2015 - 12/2009
2	Osteoporosis 04/2014 - 06/2010
2	Autoimmune Diseases (Autoimmune Disease) 02/2008 - 04/2006
1	COVID-19 01/2022
1	Bites and Stings (Sting) 01/2022
1	Hepatitis B 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Liver Neoplasms (Liver Cancer) 01/2021
1	HIV Infections (HIV Infection) 05/2020
1	Type 2 Diabetes Mellitus (MODY) 02/2020

Drug/Important Bio-Agent (IBA)

13	LigandsIBA 01/2022 - 08/2005
12	AntigensIBA 01/2022 - 12/2003
10	CytokinesIBA 01/2022 - 01/2005
10	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2003
7	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2017 - 01/2007
5	Biological ProductsIBA 01/2022 - 05/2006
5	NK Cell Lectin-Like Receptor Subfamily KIBA 01/2022 - 04/2016
5	Diphosphates (Pyrophosphates)IBA 01/2021 - 06/2010
5	Bispecific AntibodiesIBA 01/2020 - 01/2014
4	Peptides (Polypeptides)IBA 01/2017 - 06/2003
4	CaspasesIBA 10/2013 - 06/2002
4	Laminin ReceptorsIBA 06/2011 - 12/2003
3	AntibodiesIBA 01/2022 - 08/2010
3	Carrier Proteins (Binding Protein)IBA 01/2022 - 04/2016
3	ChemokinesIBA 01/2022 - 01/2003
3	InterferonsIBA 01/2022 - 01/2019
3	RNA (Ribonucleic Acid)IBA 01/2021 - 06/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2020 - 06/2002
3	Monoclonal AntibodiesIBA 01/2019 - 07/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 12/2009
3	micaIBA 01/2019 - 10/2013
3	diphosphoric acid (pyrophosphoric acid)IBA 01/2017 - 01/2010
3	Metalloproteases (Metalloproteinases)IBA 04/2016 - 10/2013
3	DisintegrinsIBA 04/2016 - 10/2013
3	Diphosphonates (Bisphosphonates)IBA 07/2015 - 06/2014
3	NitrogenIBA 07/2015 - 06/2014
3	Death Domain ReceptorsIBA 09/2014 - 06/2002
3	CeramidesIBA 02/2014 - 01/2011
3	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2011 - 07/2007
2	VaccinesIBA 01/2022 - 02/2008
2	Zoledronic Acid (Zometa)FDA Link 01/2022 - 06/2014
2	Immunoglobulin G (IgG)IBA 01/2022 - 06/2015
2	human ERBB2 proteinIBA 01/2022 - 01/2018
2	AntioxidantsIBA 01/2021 - 04/2014
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 11/2009
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 11/2016
2	Insulin (Novolin)FDA Link 01/2020 - 02/2008
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2020 - 03/2014
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2019 - 02/2014
2	Pattern Recognition ReceptorsIBA 01/2019 - 01/2008
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 05/2006
2	TNF-Related Apoptosis-Inducing LigandIBA 01/2019 - 11/2006
2	Granzymes (Granzyme)IBA 01/2019 - 11/2009
2	Trastuzumab (Herceptin)FDA Link 01/2018 - 11/2016
2	Surface Antigens (Surface Antigen)IBA 01/2018 - 03/2013
2	Interleukin-17 (Interleukin 17)IBA 01/2017 - 03/2014
2	Pharmaceutical PreparationsIBA 07/2015 - 06/2014
2	Phosphotransferases (Kinase)IBA 02/2014 - 01/2011
2	Interleukin-2 (IL2)IBA 06/2010 - 12/2004
1	citrate-binding transport proteinIBA 01/2022
1	PhycoerythrinIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	ORALIT (ORS)IBA 09/2021
1	Oxidants (Oxidizing Agents)IBA 01/2021
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2021
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 11/2020
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 11/2020
1	Galectins (Galectin)IBA 11/2020
1	CreatinineIBA 05/2020
1	Urea (Carbamide)FDA LinkGeneric 05/2020
1	Chemotactic FactorsIBA 02/2020
1	IncretinsIBA 02/2020
1	Dipeptidyl-Peptidase IV InhibitorsIBA 02/2020
1	Blood Glucose (Blood Sugar)IBA 02/2020
1	Glucose (Dextrose)FDA LinkGeneric 02/2020
1	Galectin 3 (LGALS3)IBA 01/2020

Therapy/Procedure

32	Immunotherapy 01/2022 - 12/2004
16	Therapeutics 01/2022 - 01/2002